Cross-reactivity of 4CMenB vaccine-induced antibodies against meningococci belonging to non-B serogroups in Italy-Reference-Cited by-同舟云学术

Cross-reactivity of 4CMenB vaccine-induced antibodies against meningococci belonging to non-B serogroups in Italy

Published:2021-01-31 Issue:7 Volume:17 Page:2225-2231
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Fazio Cecilia¹,Biolchi Alessia²,Neri Arianna¹,Tomei Sara²^ORCID,Vacca Paola¹,Ambrosio Luigina¹,Palmieri Annapina¹,Mori Elena²^ORCID,La Gaetana Rita²,Pizza Mariagrazia²^ORCID,Giuliani Marzia Monica²^ORCID,Serino Laura²,Stefanelli Paola¹

Affiliation:

1. Department Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy

2. GSK, Siena, Italy

Funder

GlaxoSmithKline Biologicals SA

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2020.1855951

Reference22 articles.

1. Neisseria meningitidis: using genomics to understand diversity, evolution and pathogenesis

2. European Centre for Disease prevention and Control (ECDC). Annual epidemiological report for 2017. Invasive meningococcal disease. Stockholm (Sweden): ECDC; 2019. “https://www.ecdc.europa.eu/sites/default/files/documents/AER_for_2017-invasive-meningococcal-disease.pdf” [accessed 2020 Sept 24].

3. Italian National Health Institute (Istituto Superiore di Sanità, ISS). [Surveillance data on invasive bacterial diseases updated on 23 April 2019]. Italian. http://old.iss.it/binary/mabi/cont/Interim_Report_2018_finale.pdf [accessed 2020 Sept 24].

4. Characteristics of a new meningococcal serogroup B vaccine, bivalent rLP2086 (MenB-FHbp; Trumenba®)

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Whole-genome sequencing of Neisseria meningitidis collected in Chile from pediatric patients during 2016–2019 and coverage vaccine prediction;Vaccine;2024-12

2. Temporal variations in the serogroup distribution of invasive meningococcal disease in Quebec, Canada, due to emerging unique clade of serogroup Y strain belonging to the Sequence Type-23 clonal complex;Journal of Infection;2024-06

3. Bactericidal killing of meningococcal W strains isolated in Argentina by the sera of adolescents and infants immunized with 4-component meningococcal serogroup B vaccine (4CMenB);Human Vaccines & Immunotherapeutics;2023-12-15

4. Looking beyond meningococcal B with the 4CMenB vaccine: the Neisseria effect;npj Vaccines;2021-10-29

5. Immunogenicity and safety of different schedules of the meningococcal ABCWY vaccine, with assessment of long-term antibody persistence and booster responses – results from two phase 2b randomized trials in adolescents;Human Vaccines & Immunotherapeutics;2021-09-28